 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Oct 30, 2018 |
| Title |
Transcriptomic analysis of neuroblastoma cells in response to stable over-expression of Ets-1 promoter-associated noncoding RNA (pancEts-1) |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Neuroblastoma (NB), a malignant embryonic tumor arising from primitive neural crest cells, accounts for more than 7% of malignancies and around 15% of cancer-related mortality in childhood. Better elucidating the mechanisms of tumorigenesis and aggressiveness is important for improving the therapeutic efficiencies of NB. Through mining of a public microarray dataset and rapid amplification of cDNA ends, we identified v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets-1) promoter-associated noncoding RNA (pancEts-1) as a novel lncRNA associated with the progression of NB. To investigate the mechanisms underlying the oncogenic functions of pancEts-1, we employed the Illumina HiSeq X Ten as a discovery platform to analyze the transcriptome profiling changes of human SH-SY5Y cells in response to stable over-expression of pancEts-1. The results showed that stable over-expression of pancEts-1 led to altered expression of 1912 human mRNAs, including 1035 up-regulated genes and 877 down-regulated genes. Then we found the possible roles of these differentially regulated mRNAs in selected pathways including cell cycle/proliferation, invasion, and metastasis by Bioinformatic analysis. Furthermore, we validated the RNA-seq results by real-time RT-PCR with high identity. Overall, our results provided fundamental information about the transcriptomic changes in response to pancEts-1 over-expression in human NB cells, and these findings will help us understand the pathogenesis of NB.
|
| |
|
| Overall design |
Total RNA of cells stably transfected with empty vector or pancEts-1 was extracted using the TRIzol® reagent according to the manufacturer's instructions. RNA concentration was measured using a Qubit® RNA Assay Kit with a Qubit® 2.0 Fluorometer (Life Technologies, Inc.), and integrity was assessed using the RNA Nano 6000 Assay Kit with a Bioanalyzer 2100 system (Agilent Technologies, CA). Library preparation and transcriptome sequencing on an Illumina HiSeq X Ten platform were performed by Novogene Bioinformatics Technology Co., Ltd. (Beijing, China), and 100 bp paired-end reads were generated. HTSeq v0.6.0 was used to count the reads numbers mapped to each gene.
|
| |
|
| Contributor(s) |
Qiangsong T, Liduan Z |
| Citation(s) |
29311158 |
| Submission date |
Oct 13, 2017 |
| Last update date |
Jul 25, 2021 |
| Contact name |
Qiangsong Tong |
| E-mail(s) |
qs_tong@hotmail.com
|
| Organization name |
Union Hospital of Tongji Medical College
|
| Department |
Department of Surgery
|
| Street address |
1277 Jiefang Avenue
|
| City |
Wuhan |
| State/province |
Hubei |
| ZIP/Postal code |
430022 |
| Country |
China |
| |
|
| Platforms (1) |
|
| Samples (2) |
|
| Relations |
| BioProject |
PRJNA414220 |
| SRA |
SRP119919 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE104950_RAW.tar |
380.0 Kb |
(http)(custom) |
TAR (of TXT) |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data provided as supplementary file |
|
|
|
|
 |
